Working… Menu

Crizotinib in Pretreated Metastatic Non-small-cell Lung Cancer With MET Amplification or ROS1 Translocation (METROS) (METROS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02499614
Recruitment Status : Unknown
Verified October 2017 by Fondazione Ricerca Traslazionale.
Recruitment status was:  Recruiting
First Posted : July 16, 2015
Last Update Posted : October 25, 2017
Information provided by (Responsible Party):
Fondazione Ricerca Traslazionale